Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × avelumab × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 4 Carcinoma, Transitional Cell 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Carcinoma, Renal Cell 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Lymphoma, Large B-Cell, Diffuse 1 Kidney Neoplasms 1 Kidney Diseases 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Merkel Cell 1

Interventions

Fluorouracil 58 Leucovorin 57 Oxaliplatin 39 Irinotecan 25 Folfox protocol 20 Capecitabine 18 Bevacizumab 18 Cetuximab 13 Chemotherapy, Adjuvant 11 Aspirin 6 Laparoscopy 5 Celecoxib 5 XELOX 4 Panitumumab 4 dehydroftorafur 3 Observation 3 Levamisole 3 Floxuridine 3 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Tegafur 2 Surgical Procedures, Operative 2 Standard of Care 2 Octreotide 2 Occult Blood 2 Nivolumab 2 Neoadjuvant Therapy 2 Mitomycin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03827044 2022-10-07

POLEM

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡